Know Cancer

or
forgot password

Detection and Characterization of Circulating Tumor Cells in Patients With Malignant Pleural Mesothelioma: Towards a New Phase in the Understanding of the Natural History of This Cancer?


N/A
18 Years
N/A
Open (Enrolling)
Both
Pleural Neoplasms, Mesothelioma, Pneumothorax, Parathyroid Neoplasms, Benign Tumor of the Thyroid, Tumor of the Thyroid

Thank you

Trial Information

Detection and Characterization of Circulating Tumor Cells in Patients With Malignant Pleural Mesothelioma: Towards a New Phase in the Understanding of the Natural History of This Cancer?

Inclusion Criteria


Inclusion Criteria

For the patients:

- Age > 18 years

- Patient having been operated for a strong suspicion of a pleural malignant tumoral
lesion corresponding to a primitive pleural mesothelioma

- Signed patient consent

For the control subjects:

- Age > 18 years

- unhurt of any malignant or mild tumoral pathology or patients that must benefit from
a surgical procedure for a benign lesion in other organ than the pleura or a
pulmonary non tumoral lesion

- Signed patient consent

Exclusion Criteria :

- Patient with histories of cancer or the other synchronous cancer

- Patient with additives treatments

- Patient according to treatments additives others than protocols codified (in
particular, platinum navelbine or gemcitabine platinum) for stages II

- HIV, hepatitis B or C infections

- Pregnant women

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Evaluation of presence / absence of CTC on the global survival

Outcome Description:

Value forecasts of the presence / absence of CTC on the global survival estimated by the estimation and the test of meaning at 0 of the immediate relative risk (fate ratio) in a model at proportional risk.

Outcome Time Frame:

from Baseline in Systolic Blood Pressure at 6 months

Safety Issue:

No

Principal Investigator

ILIE Marius, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

LPCE- Hôpital de Pasteur - CHU de Nice

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

11-AOI-08

NCT ID:

NCT01776385

Start Date:

February 2012

Completion Date:

March 2014

Related Keywords:

  • Pleural Neoplasms
  • Mesothelioma
  • Pneumothorax
  • Parathyroid Neoplasms
  • Benign Tumor of the Thyroid
  • Tumor of the Thyroid
  • [C08.785.640]
  • (C08.528.778)
  • [C19.642.713]
  • mesothelium
  • Neoplasms
  • Thyroid Neoplasms
  • Mesothelioma
  • Parathyroid Neoplasms
  • Pleural Neoplasms
  • Pneumothorax
  • Thyroid Diseases

Name

Location